Hsbc Holdings PLC raised its stake in shares of Xylem Inc. (NYSE:XYL - Free Report) by 10.2% in the 1st quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,490,931 shares of the industrial products company's stock after purchasing an additional 137,972 shares during the period. Hsbc Holdings PLC owned 0.61% of Xylem worth $177,969,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently bought and sold shares of XYL. NewEdge Advisors LLC increased its position in Xylem by 2.9% during the fourth quarter. NewEdge Advisors LLC now owns 4,019 shares of the industrial products company's stock worth $466,000 after purchasing an additional 112 shares during the last quarter. First Trust Advisors LP grew its stake in Xylem by 0.8% during the fourth quarter. First Trust Advisors LP now owns 618,183 shares of the industrial products company's stock worth $71,722,000 after buying an additional 4,937 shares during the period. Dimensional Fund Advisors LP grew its stake in Xylem by 6.9% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,828,304 shares of the industrial products company's stock worth $212,127,000 after buying an additional 118,692 shares during the period. Norinchukin Bank The grew its stake in Xylem by 9.8% during the fourth quarter. Norinchukin Bank The now owns 10,988 shares of the industrial products company's stock worth $1,275,000 after buying an additional 979 shares during the period. Finally, MetLife Investment Management LLC grew its stake in Xylem by 1.8% during the fourth quarter. MetLife Investment Management LLC now owns 64,278 shares of the industrial products company's stock worth $7,458,000 after buying an additional 1,145 shares during the period. Institutional investors and hedge funds own 87.96% of the company's stock.
Xylem Price Performance
Shares of XYL stock opened at $141.72 on Wednesday. The company has a market capitalization of $34.50 billion, a PE ratio of 36.81, a price-to-earnings-growth ratio of 2.44 and a beta of 1.11. The firm has a fifty day simple moving average of $133.35 and a 200-day simple moving average of $126.12. The company has a current ratio of 1.90, a quick ratio of 1.43 and a debt-to-equity ratio of 0.17. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33.
Xylem (NYSE:XYL - Get Free Report) last announced its earnings results on Thursday, July 31st. The industrial products company reported $1.26 earnings per share for the quarter, beating the consensus estimate of $1.15 by $0.11. The business had revenue of $2.30 billion during the quarter, compared to the consensus estimate of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The business's quarterly revenue was up 6.1% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.09 earnings per share. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. Equities research analysts anticipate that Xylem Inc. will post 4.65 earnings per share for the current fiscal year.
Xylem Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be paid a $0.40 dividend. The ex-dividend date is Thursday, August 28th. This represents a $1.60 annualized dividend and a dividend yield of 1.1%. Xylem's dividend payout ratio is 41.56%.
Wall Street Analysts Forecast Growth
Several research firms have issued reports on XYL. JPMorgan Chase & Co. began coverage on shares of Xylem in a research note on Friday, May 30th. They set an "overweight" rating and a $148.00 price objective for the company. Royal Bank Of Canada boosted their price objective on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research note on Wednesday, April 30th. Citigroup reiterated a "buy" rating and set a $152.00 price objective (up from $137.00) on shares of Xylem in a research note on Monday, July 14th. Robert W. Baird decreased their price objective on shares of Xylem from $149.00 to $146.00 and set an "outperform" rating for the company in a research note on Wednesday, April 30th. Finally, Stifel Nicolaus boosted their price objective on shares of Xylem from $162.00 to $175.00 and gave the stock a "buy" rating in a research note on Friday, August 1st. Six equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Xylem currently has a consensus rating of "Moderate Buy" and an average target price of $151.57.
Get Our Latest Report on XYL
About Xylem
(
Free Report)
Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.
Recommended Stories
Want to see what other hedge funds are holding XYL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Xylem Inc. (NYSE:XYL - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Xylem, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Xylem wasn't on the list.
While Xylem currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.